Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings

NCT ID: NCT01264185

Last Updated: 2022-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

751 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to conduct preparatory research needed to design a behavioral intervention to decrease sexual transmission risk behaviors in HIV-infected individuals in care and to determine whether a similar intervention structure can be used across various sexual risk groups and cultural settings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asia--Thailand; S. America--Brazil

No interventions assigned to this group

Africa--Zambia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women at least 18 years of age (Note: Pregnant and breast feeding women are allowed to enroll into the study)
* Documented evidence of HIV infection (HIV diagnosis performed outside of the trial is acceptable so long as local/country guidelines were followed in the testing)
* Receiving HIV/AIDS care (defined as at least two visits within 9 months of enrollment) in a formal health care setting (clinic or hospital)
* Reported history of sexual risk behavior in the previous 12 months, including: acquisition of a sexually transmitted infection, vaginal or anal intercourse without a condom, difficulty negotiating condom use, or non-disclosure of HIV status to an HIV-uninfected partner or partner of unknown HIV serostatus.
* NOTE: For the MSM population, we will enroll men who have sex with men, regardless of whether or not they also have sex with women

Exclusion Criteria

* Anyone currently enrolled in another study that involves protocolized HIV risk reduction counseling (e.g. ACTG 5175 or HPTN 052) or any other prevention study
* Anyone having unprotected (i.e. without a condom) sex for the expressed purpose of conceiving
* Planning to relocate out of the area in the next year
* Any condition that, in the opinion of the Investigator of Record or designee, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HIV Prevention Trials Network

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steve Safren, PhD

Role: STUDY_CHAIR

Fenway Community Health Center

Ken Mayer, MD

Role: STUDY_CHAIR

Fenway Community Health Center

Stewart Reid, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Centre for Infectious Disease Research in Zambia (CIDRZ)

Ruth Friedman, MD

Role: PRINCIPAL_INVESTIGATOR

Instituto de Pesquisa Clincia Evandro Chagas (IPEC) Clinical Research Site (CRS)

Kriengkrai Srithanaviboonchai, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Chiang Mai University AIDS CRS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto de Pesquisa Clinicaq Evandro Chagas CRS

Manguinhos, Rio de Janeiro, Brazil

Site Status

Chiang Mai University AIDS CRS

Chiang Mai, , Thailand

Site Status

Matero Reference Clinic

Lusaka, , Zambia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil Thailand Zambia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HPTN 063

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Linkage to Care - Part I
NCT00703040 COMPLETED